Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May

16May

Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May

Portfolio News
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company focused on treating inflammatory and fibrotic diseases by targeting the endocannabinoid system, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present at two upcoming investor conferences in May. Read more >>

Share this post

Related Posts

10Dec

All-Star Athletes Across Sports Are Seeing Injury Recovery Without Surgery or Medication Using SAM 2.0 Wearable Ultrasound

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device supported by the... read more
29Mar

Corbus Pharmaceuticals Provides Management Team Updates

Corbus Pharmaceuticals Holdings, Inc. today announced several changes to its management team. Read more >> read more
20Dec

Corbus Readies Pivotal Phase 3 Trial of Anabasum, Possible Scleroderma Treatment

Corbus Pharmaceuticals is planning a global Phase 3 trial to assess anabasum (JBT-101) as a treatment for scleroderma. If successful,... read more
11Aug

New technology is helping visually impaired pianist see his sheet music and audience

Fournier was diagnosed with a severe visual impairment when he was 3. "It’s the optic nerve that’s wrong. The eyes... read more
16Nov

New Hampshire Society for Technology in Education (NHSTE) Partners with Scrible to Help Schools Affordably Access Its Research and Writing Platform

Scrible, a modern research and writing platform for students, teachers and librarians, announced today a new partnership with the New... read more
20Jan

VentureSouth invested $12M in 34 companies in 2022

VentureSouth, one of the Top 10 angel investment groups in North America, provided $12 million in capital investment to 34... read more
15Mar

Wasabi Technologies opens its first German storage region in Frankfurt to drive European and global expansion

Wasabi Technologies, the hot cloud storage company, today announced the opening of its first German storage region in Frankfurt, Germany.... read more
02Jun

The delivery of sight

Tina Leonard's new eSight electronic glasses came in the mail last week, and for the first time in five years,... read more
07Oct

Corbus Pharmaceuticals Announces Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis Did Not Meet Primary Endpoint

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced topline... read more
23May

Fishmeal substitute passes taste test

Sashimi derived from yellowtail fed a diet containing a novel fishmeal replacement has passed a consumer taste test with flying... read more